Patient case study: Assessing recurrence risk in HR+/HER2- early breast cancer

Current Status
Not Enrolled
Get Started

Publication date: 3rd October 2022
In this case study module, Sung-Bae Kim discusses key risk factors for disease recurrence in HR+/HER2- early breast cancer and outlines the prognostic tools that can be used for to help predict the risk for this, with reference to the disease course of a 34-year old HR+/HER2- early breast cancer patient.

Learning objectives

After completing this activity, you will be able to:

  • Describe the prognostic variables which can influence recurrence risk in HR+HER2- early breast cancer
  • Explain the methods that can help determine prognosis and treatment efficacy


Expiration date: 3rd October 2023
Estimated time to complete: 15 minutes 

When you have completed this activity you will be asked to fill in a short evaluation survey. Your feedback helps us to give you the best learning experience.

In support of improving patient care, this activity is accredited by North American Center for Continuing Medical Education (NACCME) for 0.25 AMA PRA Category 1 Credit(s)™. Should you wish to claim credits for this activity, please select “yes” in the evaluation survey when directed and download your certificate. Should you simply wish to provide us with valuable feedback, please select “no” when directed and submit your feedback.

Sign up for new content alerts

Enter your email address below and we'll contact you as soon as new content is launched!

HCP confirmation(Required)
Privacy Policy Acceptance(Required)
This field is for validation purposes and should be left unchanged.

Create your first navigation menu here

Login / register

"*" indicates required fields

Healthcare Professional

Can you spare 2 minutes to share some feedback?